Earningsreport

Q1/2024 3/31/2024 EPS -0.100 ZacksConsensus -0.110 ActVsEst 0.010 - Beat

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com